<unk>  studies are required to better understand the association between the different manifestations of the disease, and the respective bacterial genotypes. Additionally it is necessary to create humanized mouse models that will allow us understand the pathophysiology of the disease, and to test new drugs and vaccines. Current drugs undergoing investigation include: new antibiotics, electrolyte absorption enhancers; blockers of inflammatory and secretory toxins; and promoters of the intestinal repair.
Salmonellosis future or investigational therapies
Listeriosis future or investigational therapies
Salmonellosis primary prevention
Yersinia pestis infection future or investigational therapies
Yersinia pestis infection medical therapy
Brucellosis primary prevention
Yersinia pestis infection primary prevention
Salmonella primary prevention